Preeclampsia Intervention Netherlands

计划入组 180 人 · 首次发布于 2024 年 6 月 11 日

Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis

计划入组 54 人 · 首次发布于 2021 年 11 月 10 日

Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors

计划入组 57 人 · 首次发布于 2025 年 7 月 25 日

BSI-118

BSI-082

BSI-715

Curium Netherlands B.V.

Netherlands

Atnahs Pharma Netherlands B.V.

Seqirus Netherlands B.V.

Netherlands

LeukoStrat® CDx FLT3 Mutation Assay Receives EU Approval for AML Treatment Selection

Invivoscribe Achieves IVDR Class C Certification for B-Cell Lymphoma Diagnostic Assay in Europe

Biosion Initiates Phase 1 Trial of BSI-082 Anti-SIRPα Antibody for Advanced Solid Tumors